Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives
Rebecca Liu,1 Kyle Staller1,2 1Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; 2Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USACorrespondence: Kyle StallerMassachusett...
Main Authors: | Liu R, Staller K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/update-on-eluxadoline-for-the-treatment-of-irritable-bowel-syndrome-wi-peer-reviewed-article-DDDT |
Similar Items
-
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome: The SEPD perspective
by: Isabel Vera, et al. -
Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
by: Fragkos KC
Published: (2017-09-01) -
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Özdener AE, et al.
Published: (2017-09-01) -
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Sobolewska-Włodarczyk A, et al.
Published: (2016-05-01) -
Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
by: Annamaria Altomare, et al.
Published: (2021-04-01)